Announced Thu, 9 Jul · 15:47 IST
Routine RTA certificate under SEBI Reg 74(5) for Q1 FY27
Compliance View source PDF
BAFNAPH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹200.60
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+6.1+8.2+10.4+12.6+16.4————
Up moveDown movePending
AI summary
Bafna Pharmaceuticals submitted a routine compliance certificate from its Registrar and Share Transfer Agent, Cameo Corporate Services, under SEBI Regulation 74(5) for the quarter ended June 30, 2026. The certificate confirms that securities received for dematerialization were processed and listed on stock exchanges, and physical certificates were mutilated and cancelled within the prescribed timeline.
Likely market impact
No impact on shareholders; standard quarterly compliance filing with no business or price implications.